Felson D T, Anderson J J
Arthritis and Musculoskeletal Diseases Center, Boston University School of Medicine, MA 02118-2394, USA.
Baillieres Clin Rheumatol. 1995 May;9(2):253-66. doi: 10.1016/s0950-3579(05)80189-x.
We have discussed methodological and statistical considerations in developing disease classification and assessment criteria. In choosing cases with disease and nondisease controls, classification criteria should be developed with an eye toward face, content and construct validity, and toward their ultimate applicability. The validity of disease criteria should be tested in a patient sample different from the one used to develop the criteria. Several analytic approaches are available to reduce the candidate diagnostic elements to those that will define the presence of disease. Methodological issues in the assessment of disease severity, activity or damage are similar to those faced in criteria development studies, although the analytic concerns are different and the options more varied.
我们已经讨论了制定疾病分类和评估标准时的方法学和统计学考量。在选择患有疾病的病例和无疾病的对照时,制定分类标准应着眼于表面效度、内容效度和结构效度,以及其最终适用性。疾病标准的效度应在不同于用于制定标准的患者样本中进行检验。有几种分析方法可用于将候选诊断要素缩减至能确定疾病存在的要素。评估疾病严重程度、活动度或损害的方法学问题与标准制定研究中面临的问题相似,尽管分析关注点不同且选择更多样化。